Dr Salil Vengalil

Profile

Dr Salil Vengalil has been working as Consultant Clinical Oncologist at the University Hospital of North Midlands (UHNM) since 2013. He has expertise in oncological treatment of patients with prostate cancer, Bladder cancer, Kidney cancer, Lung cancer, Mesothelioma, Melanoma and non-melanoma skin cancers.

Referral Criteria: Patients requiring opinion and oncological management for the above conditions can be referred. Dr Vengalil would also be happy to accept referrals for second opinions. Private patient Consultation will be arranged at the Nuffield Health North Staffordshire Hospital.

Dr Vengalil has previously worked in the world-renowned Princess Margaret Hospital, Toronto (Canada) where he completed radiation oncology fellowship gaining further experience in advanced radiation techniques. His areas of interest in radiotherapy include Intensity modulated radiation therapy (IMRT), Image guided radiation therapy (IGRT), Stereotactic body radiotherapy (SBRT) and adaptive radiotherapy. Prostate cancer patients will also be given the option of having spaceOAR insertion arranged through genesis care team prior to prostate radiotherapy treatment.

Dr Salil Vengalil is an expert in radiotherapy, chemotherapy, targeted therapy, immunotherapy, hormone therapy and radionuclide treatments in oncology. He has led the team in setting up and implementing Radium 223 treatment service for metastatic prostate cancer patients at UHNM. He has a very keen interest in research and had been principal investigator for several commercial and non-commercial trials.

Dr Vengalil had also served as a Clinical lead in Oncology at the University Hospital North Midlands NHS Trust and is currently the oncology lead for urological cancers. Dr Vengalil is also member of the West midlands Genomic Tumour Advisory Board.